Looking After Your Mental Wellbeing with Aspergillosis
Originally published: 18 May 2020 | Last reviewed: 18 September 2026 | Next review: September 2028
Living with aspergillosis can affect more than your lungs. Symptoms may be unpredictable, treatment can be demanding, and it can be hard to plan around fatigue, appointments, infections or flare-ups. It is understandable to feel anxious, low, frustrated, isolated or worn down at times.
Looking after your mental wellbeing is not a luxury or an optional extra. It can make it easier to cope with symptoms, make treatment decisions and stay connected to the things that matter to you.
There is no “right” way to feel
A diagnosis of aspergillosis, or a change in your health, can bring many different reactions. You may feel relieved to have an explanation for your symptoms, but also worried about the future. You may grieve for activities or independence you have lost. Some days you may feel positive and capable; on others, even small tasks may feel difficult.
These reactions do not mean that you are failing to cope. Chronic illness asks a great deal of people, and feelings can change over time.
Focus on what you can influence
Aspergillosis often involves uncertainty. You cannot control every symptom, test result or appointment outcome, but it can help to identify the small things you can influence today.
- Take medicines and treatments as agreed with your clinical team.
- Keep a short note of symptoms, questions or changes you want to discuss at an appointment.
- Plan a manageable activity that gives your day some structure or enjoyment.
- Build in rest before you become exhausted, rather than treating rest as something you have to earn.
- Choose one reliable source of health information instead of repeatedly searching online.
Stay connected in ways that work for you
Illness can make it easier to withdraw from other people, especially if you are tired, breathless or worried about infection. But connection can be protective. A short phone call, message, online meeting or a gentle outing with someone you trust can make a real difference.
You do not have to explain every detail of aspergillosis. It can be enough to say: “I am having a difficult health day and would appreciate some company,” or “I cannot manage a long visit, but I would like to keep in touch.”
The Aspergillosis Support and Community page includes information about our online meetings and other ways to connect with people who understand some of the challenges of living with aspergillosis.
Be kind to your body and your energy
Your physical and mental wellbeing are closely linked. Gentle, regular routines can help, but they should be adapted to your health and energy—not based on what you think you “should” be able to do.
- Keep as regular a sleep routine as possible.
- Eat and drink regularly, particularly when symptoms or medication affect appetite.
- Include movement that is safe and realistic for you, such as a short walk, stretches, breathing exercises or a programme recommended by your physiotherapist.
- Make time for something absorbing or enjoyable: music, reading, gardening, crafts, a favourite programme or talking with someone you like.
- Notice whether alcohol, smoking, poor sleep or relentless activity are making your mood or symptoms harder to manage.
Make room for difficult thoughts
Trying to push away every worry can sometimes make it more persistent. It may help to name what is happening: “I am feeling frightened about my symptoms today,” or “I am worried because I do not yet have an answer.”
Talking to someone you trust can reduce the pressure. Some people find it helpful to write worries down, practise relaxation or mindfulness, or set aside a short, specific time to think through a concern rather than allowing it to take over the whole day.
If health news or social media leaves you more anxious, consider limiting it to a set time each day and using trustworthy sources. You do not need to follow every new story to be well informed.
Ask for support early
Please speak to your GP, respiratory team or another healthcare professional if low mood, anxiety, panic, poor sleep or loss of interest in everyday life is lasting, worsening or affecting how you manage. Support can include practical advice, talking therapies, medication where appropriate, or referral to local services.
The NHS Every Mind Matters website has practical tools and advice for managing stress, anxiety, sleep and low mood.
Urgent mental-health support
If you or someone else is in immediate danger, call 999 or go to A&E. For urgent mental-health support in England, call 111 or use NHS 111 online and select the mental-health option. You do not have to manage a crisis alone.
Further information
- Mental health and anxiety
- Aspergillosis support and community
- NHS Every Mind Matters
- NHS mental health information and support
Hope on the horizon: Novel antifungal treatments in development
For many people with aspergillosis, today’s antifungal medicines make a real difference. They can control infection, improve symptoms and help prevent further lung damage. However, treatment can also be difficult: medicines may cause side effects, interact with other drugs, be hard to absorb consistently, or become less effective if the fungus is resistant.
That is why researchers are developing new antifungal treatments. This is encouraging progress, but it is important to be clear about what it means: a medicine in development is not yet a treatment option for most people. It must first be tested carefully for safety, the right dose and whether it works better than, or alongside, existing treatment.
Key points
- Existing antifungal medicines remain the standard treatment for aspergillosis.
- New medicines may eventually offer more options where current treatment is unsuitable, ineffective or limited by resistance.
- Clinical trials are essential, but joining one is not right or possible for everyone.
- Never stop, reduce or change an antifungal medicine because you have read about a possible new treatment—speak to your specialist team first.
Why are new antifungals needed?
Aspergillosis is not one single illness. It includes allergic conditions such as ABPA, chronic pulmonary aspergillosis (CPA), aspergilloma and severe invasive infection. The right treatment depends on the type of aspergillosis, how active it is, a person’s underlying lung health and immune system, and the results of scans, blood tests and microbiology.
The azole antifungals—such as itraconazole, voriconazole, posaconazole and isavuconazole—are important treatments. They have helped many people live with and manage aspergillosis. Yet they can be challenging because:
- levels of some medicines vary between people, so blood-level monitoring may be needed;
- they can interact with other prescribed medicines, over-the-counter remedies and supplements;
- some people experience troublesome side effects or changes in liver blood tests;
- Aspergillus can sometimes be resistant to azole treatment;
- some people have complex illness that needs a different approach, combination treatment or specialist advice.
New treatments are being designed to work in different ways from older medicines. In time, this may provide alternatives for people who cannot tolerate an existing medicine, whose infection is resistant, or whose illness has not responded as hoped.
What is being developed?
There are several investigational antifungal medicines and approaches in development. Not all will become licensed treatments, and not every medicine being studied is aimed specifically at every form of aspergillosis.
Medicines with new targets
Most established antifungals work by disrupting parts of the fungal cell membrane or cell wall. Several newer medicines aim at different fungal processes. This matters because a different target may mean a medicine can still work when resistance or intolerance limits another option.
Olorofim is one example of a newer oral antifungal that has been studied for difficult-to-treat invasive fungal infections, including infections caused by Aspergillus. It works differently from azole medicines. Research has particularly focused on situations where established treatment is unsuitable or has not worked.
Fosmanogepix is another investigational antifungal with a different mechanism of action. It has been studied in serious invasive fungal infections and has attracted interest because of its activity against a range of fungi. Its eventual role, if licensed, will depend on the results of clinical studies and decisions by medicines regulators.
Weekly intravenous treatment: rezafungin
Rezafungin is a newer echinocandin antifungal given by intravenous infusion, usually once a week. Echinocandins work differently from azole medicines: they interfere with the fungal cell wall. Rezafungin is already used for some serious fungal infections, but its role in aspergillosis is still being researched.
A clinical study is assessing whether six months of rezafungin treatment can be helpful and safe for people with chronic pulmonary aspergillosis (CPA) who have limited treatment options. A once-weekly treatment could be particularly useful for some people who cannot take, absorb or tolerate long-term oral azoles. However, it remains a clinical-trial treatment for CPA rather than standard care.
Getting treatment directly to the lungs
Researchers are also exploring whether antifungal medicines can be delivered directly to the lungs by inhalation. Pulmazole, an inhaled formulation of itraconazole, was developed with this aim: high levels of medicine at the site of infection, with less medicine circulating around the rest of the body.
This approach is appealing, particularly for long-term lung conditions, but inhaled antifungal treatment is not currently routine care for aspergillosis. Pulmazole is best understood as an example of an important research direction rather than an available treatment. Other inhaled antifungal formulations have also been investigated.
Other medicines and treatment strategies are also being explored. These include new formulations, possible combination approaches and treatments designed to address resistant fungi. Research is active, but progress is rarely straightforward: studies may change, take longer than expected or show that a medicine is useful only for a particular group of patients.
What does “in development” actually mean?
Before a medicine can be routinely prescribed, it usually passes through several stages of research. Early studies look at safety and how the body handles the medicine. Later studies assess dose, side effects and whether it works in people with the infection it is intended to treat.
Even when early results are promising, researchers still need to establish important questions:
- Who is most likely to benefit?
- What dose is safest and most effective?
- How does it compare with current treatment?
- Does it work against resistant infection?
- What side effects, interactions and monitoring are needed?
- Can it be used safely with other treatments people may need?
Only after sufficient evidence has been reviewed can a regulator decide whether to license a medicine for a particular use. A medicine may be available in one country but not another, or only for a specific type of infection.
Clinical trials: a route to better treatment
Clinical trials are how new treatments become available. People who take part contribute to better care for future patients, and some may gain access to a treatment not otherwise available. However, a trial is not simply a way to obtain a new medicine.
Every study has strict eligibility criteria. These may relate to the type of aspergillosis, scan findings, fungal culture results, previous antifungal treatment, other medicines, liver or kidney function, and whether someone has another health condition. Some trials compare a new medicine with usual care; others do not provide the study medicine to every participant.
If you hear about a trial and wonder whether it may be relevant, ask your treating respiratory, infectious diseases or aspergillosis specialist. They can advise whether it is appropriate and, if needed, seek specialist or trial-centre advice. It is completely reasonable to ask—but it is equally reasonable for the answer to be that current treatment remains the better option for you.
What about off-label or unlicensed treatment?
Sometimes a specialist may consider an antifungal medicine outside its usual licence. This may be described as off-label use: the medicine is licensed, but not specifically for your type of aspergillosis, dose or treatment situation. This is not unusual in complex or rare diseases, but it requires careful specialist judgement, discussion of the uncertainty, and appropriate monitoring.
In exceptional circumstances, an investigational medicine may also be available through a clinical trial, a named-patient arrangement or an early-access programme. These routes are tightly controlled and are not a guarantee of treatment. They are usually considered only when standard options have been unsuitable, ineffective or cannot be used safely.
Whether any of these options is appropriate depends on your diagnosis, previous treatment, fungal test results, other health conditions and the potential balance of benefit and risk. Your specialist team can advise whether there is a realistic route worth exploring.
What this means for you now
News about new antifungal medicines can bring hope, particularly if you have had a difficult experience with treatment. It can also create uncertainty or make you question a medicine you are taking now. The most important point is that treatment decisions should be based on your current health, diagnosis and test results, not on headlines about a treatment that may still be years away from routine use.
If your current antifungal is helping, monitoring and review are part of making that treatment as safe and effective as possible. If you are struggling with side effects, taking other medicines, finding doses difficult, or worrying that treatment is not working, tell your team. There may be practical solutions, such as checking drug levels, reviewing interactions, changing the timing or formulation of a medicine, managing side effects, or considering an alternative treatment.
Do not feel that you have to “put up with” problems in silence. Equally, do not stop an antifungal suddenly unless a clinician has advised you to do so. A supported discussion with your specialist team is the best way to balance the benefits and risks of treatment.
Questions you may want to ask at an appointment
- What is the aim of my antifungal treatment at the moment?
- How will we know whether it is working?
- Do I need blood tests or antifungal drug-level monitoring?
- Could any of my other medicines, vitamins or supplements interact with it?
- What symptoms or side effects should I report promptly?
- Is there a different treatment approach if this medicine is not suitable for me?
- Are there any relevant clinical trials now or likely in the future?
Keeping hope realistic
There is genuine momentum in antifungal research. New medicines, better diagnostics and greater awareness of fungal disease all have the potential to improve care. But good care today still depends on timely diagnosis, expert interpretation of tests, careful monitoring and shared decisions between patients and their clinical teams.
The future is promising—not because every new medicine will be right for every person, but because more research should mean more informed choices when people need them.
This page is for general information and does not replace personalised medical advice. If you have concerns about your antifungal treatment, contact your prescribing clinical team or specialist.
Living with aspergillosis: managing stress, energy and change
A Thursday Session introduction
This article introduces next week’s Thursday Session: an informal conversation about finding a balance between taking good care of your health and protecting the parts of life that matter to you. You are very welcome to join in, or simply listen.
You can find details of the National Aspergillosis Centre’s regular online support meetings here.
Taking the condition seriously — without letting it take over
Many people describe two feelings that seem to pull in opposite directions.
One is the wish to fight the illness: to understand it, follow treatment, attend appointments, notice meaningful changes and do what they can to stay well.
The other is the need to accept that some symptoms, uncertainty or limits may remain.
These are not opposites. Acceptance does not mean giving up, ignoring symptoms or deciding that nothing can improve. It can mean recognising what is outside your control at the moment, while putting your energy into the things that are helpful and important to you.
That might include taking prescribed treatment, keeping active within your limits, resting when needed, staying connected with other people, and making room for interests, family, work or small everyday pleasures. The aim is not to manage everything perfectly. It is to develop a routine that supports your health without making illness the centre of every day.
Stress uses energy
Stress does not cause aspergillosis, and difficult symptoms are not “all in the mind”. But prolonged stress can make a long-term condition harder to live with.
When someone is worried for weeks or months, sleeping badly, managing caring responsibilities, facing money or work pressures, or constantly watching for symptoms, there may be little opportunity to recover. That can leave less energy for treatment routines, activity, eating well, social contact and the ordinary tasks of life.
A useful question is not simply, “How can I avoid stress?” Few of us can avoid it altogether. It may be more helpful to ask:
- Which things are draining my energy most at the moment?
- What helps me recover some of that energy?
- What is one useful thing I can do for my health today?
- What can wait until tomorrow?
Recovery is not laziness or failure. Rest, a short walk, a conversation, a hobby, time outdoors, music or a good routine before bed may all be part of managing a long-term condition well.
Finding a manageable pace
Some activities take energy but give something back: meeting a friend, gentle exercise, a rehabilitation session, a favourite pastime or a family event. Other demands can become overload, particularly when there is no time to rest afterwards.
It may help to plan rather than wait until exhaustion forces you to stop. This can mean breaking tasks into smaller parts, choosing priorities, allowing recovery time after a busy day and being realistic about what can fit into a week.
There will be days when the condition needs more attention, and days when it is reasonable to put it in the background. Both can be sensible.
Coping with change and uncertainty
It can be stressful when doctors use new language or when the plan changes. For example, people may hear terms such as colonisation, infection or microbiome.
These words do not necessarily mean that clinicians are less certain or that treatment has become less effective. Often, they reflect a more detailed understanding of what is found in samples and how it relates to the person’s symptoms.
A sputum sample may show bacteria or fungi that are present in the airways without causing a current deterioration; this is often called colonisation. An infection is considered in the wider clinical picture — including new or worsening symptoms, test results, scans and how the person is feeling.
It is always reasonable to ask:
- What does this result mean for me?
- Do you think this is colonisation or active infection?
- Why is this treatment recommended now?
- What changes should make me contact the team?
Clear questions can help turn uncertainty into a plan.
Support beyond medical treatment
Clinical care is essential, but people often need more than a prescription or test result. They may need time to talk, practical advice, reassurance, emotional support and a sense that they are being treated as a whole person.
Some people find peer support, counselling, relaxation, mindfulness or hypnotherapy helpful for stress, sleep, anxiety or coping with symptoms. These approaches may support wellbeing, but they do not replace prescribed treatment for suspected infection or worsening lung disease.
If you use supplements, herbal products or complementary remedies, tell your clinical team. Some products can interact with prescribed medicines, including antifungal treatment.
Patient voices and shared learning
Marcela also shared some early reflections today from the recent ERS/ELF conference, where patients and professionals came together to discuss how people with lung conditions can be partners in care, research and service improvement. We will publish a fuller report shortly.
It is a useful reminder that living well with a long-term condition is not only about medical treatment. Patients’ experience — including what helps, what creates stress and what support is missing — has an important place in shaping better care.
Join the conversation
Next week’s Thursday Session will explore:
Living with long-term illness: managing stress, energy and change
There are no right answers and no expectation to speak. You are welcome to share what has helped you, ask a question, or simply listen to others’ experiences.
Antifungal Medicines and Your Liver: Monitoring, Symptoms and Safe Use
Some antifungal medicines used to treat aspergillosis can affect the liver. This does not mean that liver damage is expected, or that treatment is unsafe. It means that antifungals need regular monitoring so that possible problems can be recognised early and managed safely.
For most people, treatment can continue successfully with the right dose, blood tests and communication between the patient, prescriber and specialist pharmacist.
If you feel worried about starting an antifungal
It is understandable to feel anxious when you read a long list of possible side effects. Antifungal medicines are powerful treatments, and they do need careful monitoring. But a side effect listed in the information leaflet is a possibility, not something that will happen to everyone.
Your clinical team has recommended treatment because they believe the likely benefit—controlling infection, reducing symptoms or preventing further lung damage—outweighs the risks in your situation. Blood tests, medicine reviews and antifungal drug levels are there to make treatment safer and to identify problems early.
If a medicine does not suit you, there are usually options: adjusting the dose, reviewing interactions, changing the formulation, trying another antifungal or agreeing a different treatment plan. You do not have to manage worrying symptoms alone, and reporting a possible side effect is not “making a fuss”.
The best starting point is usually to take the medicine as prescribed, attend monitoring appointments and tell your team honestly about any concerns. A planned, supported decision is safer than avoiding treatment because of fears about what might happen.
Key points
- Azole antifungals, including itraconazole, voriconazole, posaconazole and isavuconazole, can sometimes affect liver blood tests.
- Regular blood tests are a safety measure. They help clinicians detect change early, often before you feel unwell.
- Do not stop, reduce or restart an antifungal medicine without advice from the team prescribing it.
- Tell your team about every medicine, supplement and herbal product you take. Interactions and unrecognised ingredients can matter.
- Contact your healthcare team promptly if you develop symptoms that could suggest a liver problem, especially yellowing of the skin or eyes, dark urine, pale stools, severe nausea or unusual tiredness.
Why does liver safety matter with antifungal medicines?
The liver processes many medicines and helps remove them from the body. Azole antifungals are effective treatments for several forms of aspergillosis, but they can be difficult for the body to handle and can interact with many other medicines.
Some people develop changes in liver blood tests after starting an antifungal or after a dose change. These changes are often mild and reversible. Sometimes the result simply needs repeating; sometimes it prompts a review of the dose, a check for another cause or a switch to a different medicine.
The important message is that monitoring allows the clinical team to make a planned, early decision. It is not a sign that treatment has failed.
What blood tests are used?
You may hear these called liver function tests, or LFTs. They are a group of blood tests that can show whether the liver is irritated, under stress or having difficulty processing substances.
Results may include enzymes such as ALT, AST and ALP, as well as bilirubin. Your team looks at the overall pattern and how it has changed over time; one result on its own does not always tell the full story.
Abnormal liver tests do not automatically mean permanent liver damage. They can be affected by medicines, alcohol, infection, fatty liver disease, gallbladder problems and many other conditions. This is why clinicians may repeat the test or investigate further before changing treatment.
How often will I need monitoring?
The timing depends on the antifungal medicine you take, your dose, your other health conditions, any previous liver problems and whether you are taking medicines that interact with antifungals.
Blood tests are commonly done before treatment starts, after starting or changing a dose, and then at intervals during longer-term treatment. You may also have antifungal blood-level testing. This shows how much medicine is in your bloodstream and can help the team balance effectiveness against side effects.
Attend requested blood-test appointments, even when you feel well. Early changes are often found on a blood test before symptoms develop.
Symptoms to report promptly
Many people have no symptoms even if a liver test changes. However, contact your GP, specialist team or pharmacist promptly if you develop:
- yellowing of the eyes or skin (jaundice);
- dark urine or unusually pale stools;
- new or persistent nausea, vomiting or loss of appetite;
- unusual tiredness, weakness or feeling generally unwell;
- itching without an obvious cause;
- pain or tenderness under the ribs on the upper-right side of your abdomen.
These symptoms can have many causes and do not necessarily mean that an antifungal is responsible. They are worth reporting so that your team can decide whether blood tests or other assessment are needed.
Seek urgent medical help if you become severely unwell, confused, very drowsy, develop rapidly worsening jaundice, or have any other medical emergency.
Do not stop treatment on your own
It can be worrying to read about liver side effects, particularly when you are taking an antifungal for months or years. But suddenly stopping treatment can allow fungal disease to worsen and may leave fewer treatment options.
If blood tests change or you develop possible side effects, the team may:
- repeat blood tests sooner;
- check your antifungal blood level and the timing of your dose;
- review other medicines, alcohol use, supplements or another possible cause;
- reduce, pause or change treatment under supervision; or
- switch to a different antifungal where appropriate.
These are normal safety decisions. They are tailored to the balance between controlling aspergillosis and protecting your overall health.
Medicines, supplements and interactions
Azole antifungals can interact with many commonly prescribed medicines, including some inhaled and oral steroids, heart-rhythm medicines, blood thinners, pain medicines and treatments for seizures or mental health conditions.
Always tell your prescriber and pharmacist about:
- prescription medicines from any clinic or hospital;
- medicines bought from a pharmacy or supermarket;
- cold and flu remedies, painkillers and indigestion treatments;
- vitamins, bodybuilding products, herbal remedies and supplements; and
- anything you have recently started, stopped or changed.
“Natural” does not automatically mean safe. Some supplements and herbal products can affect the liver, interact with medicines or contain ingredients that are not obvious from the label. There is no reliable “liver detox” product that protects the liver from antifungal side effects.
If you are considering a supplement, ask your pharmacist or specialist team first—especially if it claims to cleanse, detoxify or support the liver.
Alcohol and antifungal treatment
Alcohol can affect the liver and may make it harder to interpret liver-test changes. The safest approach is to discuss your own alcohol use with the clinician prescribing your antifungal, particularly if you have previously had abnormal liver tests, known liver disease or take several medicines.
Do not assume that a product is safe simply because it is low alcohol, occasional or sold as a supplement. If you have been advised to avoid alcohol with your treatment, follow that advice.
Everyday liver health
You do not need a special “liver diet”. The most useful foundations are the same ones that support overall health:
- eat a balanced diet that you can maintain;
- stay active within your abilities and physiotherapy advice;
- aim for a healthy weight where this is appropriate for you;
- avoid smoking;
- follow advice about vaccination, including hepatitis vaccination if it is recommended for your circumstances; and
- seek help for alcohol use if it is becoming difficult to control.
Be cautious with paracetamol and combination cold-and-flu medicines. Several products may contain paracetamol, making it easy to take more than intended. Check with a pharmacist or clinician if you have liver disease, drink alcohol regularly, are underweight, or are unsure which pain relief is safe for you.
Questions to ask at your next appointment
- How often should I have liver blood tests?
- Do I need antifungal blood-level monitoring?
- Which symptoms should I report to your team, and who should I contact?
- Are any of my medicines or supplements likely to interact with my antifungal?
- Is alcohol safe for me while taking this medicine?
For more information about doses, blood levels, interactions and specialist care, see Antifungal Medicines: Dosing, Monitoring, and the Role of Specialist Care.
This information is for general education and does not replace advice from the team prescribing your antifungal treatment. Your monitoring plan should be based on your medicine, dose, test results and individual medical history.
Stopping Antifungal Treatment for CPA: Relapse, Monitoring and What Happens Next
For people with chronic pulmonary aspergillosis (CPA), taking antifungal treatment for months or years can be demanding. You may be dealing with side effects, blood tests, drug-level monitoring, interactions with other medicines and the worry of what will happen if treatment is reduced or stopped.
It is natural to ask: “Has the infection settled enough for me to stop?” and “If it comes back, what then?”
There is no single answer that applies to everyone. Some people can stop antifungal treatment safely after a period of stability. Others need treatment for longer, sometimes indefinitely. The decision is based on the whole clinical picture—not one blood result, scan or time period.
Key points
- Do not stop or reduce an antifungal medicine without discussing it with your specialist team.
- CPA can become active again after treatment stops, but this does not happen to everyone.
- Stopping treatment is usually a planned decision, followed by clinical review, blood tests and sometimes imaging.
- If CPA returns, there are often further treatment options. A relapse is not a personal failure.
Why might antifungal treatment be stopped?
Antifungal medicines are used in CPA to control fungal infection, reduce symptoms and help prevent further lung damage. Treatment is often continued for at least several months, but the right duration varies greatly.
Your team may consider stopping treatment when CPA appears stable and the balance of benefit and burden has changed. For example:
- symptoms have improved or remained stable;
- scans show that cavities, nodules or areas of inflammation are stable or improving;
- blood tests and fungal markers support clinical stability;
- there is no evidence of ongoing active infection on sputum or other samples, where these are available;
- you are experiencing significant side effects, interactions or difficulty tolerating treatment;
- there is a concern about antifungal resistance or the medicine is no longer suitable.
Sometimes treatment is stopped because a person has reached a stable remission. At other times, it is stopped because continuing the medicine is causing more harm or difficulty than benefit. These are different situations, which is one reason relapse risk cannot be reduced to a simple percentage.
Can CPA return after treatment stops?
Yes, CPA can become active again after antifungal treatment is stopped. This may be described as relapse, recurrence or reactivation. However, it is important not to assume that this will happen to you.
An earlier National Aspergillosis Centre study reviewed 102 people whose antifungal treatment had been stopped. CPA returned in around one in five people during follow-up. This is useful evidence, but it should not be used as a personal prediction. The people in the study had different forms and severity of CPA, different underlying lung conditions, and different reasons for stopping treatment. Many had treatment stopped because of side effects or resistance rather than because the infection had fully settled.
Your individual outlook may be better or worse than the average in any study. Your specialist will use your own history, symptoms, scans, test results and treatment experience to guide the discussion.
What can make relapse more likely?
Doctors cannot always predict whether CPA will return. However, some features may suggest a higher risk and may influence how cautiously treatment is reduced or stopped.
These can include:
- More widespread lung involvement, particularly disease affecting both lungs or several lobes;
- Aspergilloma or persistent cavities, especially if there is continuing evidence of active disease around them;
- Underlying lung damage, such as bronchiectasis, COPD, previous tuberculosis, fibrosis or other structural lung disease;
- Other lung infections, including bacterial infection or non-tuberculous mycobacterial infection;
- Difficulty reaching a stable response during previous treatment;
- Antifungal resistance, poor absorption or treatment intolerance, which can limit the options available;
- Immune suppression or another health condition that makes infection more difficult to control.
These are not rules. Someone with a cavity or disease in both lungs may still remain stable after treatment stops. Someone whose scans look relatively reassuring may still need further treatment later. The purpose of identifying risk factors is to plan sensible monitoring—not to create unnecessary anxiety.
What does a planned stop usually involve?
Stopping treatment should be a shared decision. Beforehand, your team will usually review whether there is enough evidence that CPA is stable and whether the potential benefits of continuing still outweigh the downsides.
The plan may include:
- a review of cough, breathlessness, fatigue, chest discomfort, weight and general wellbeing;
- blood tests, which may include inflammatory markers, liver tests and Aspergillus-related tests where relevant;
- sputum testing or other microbiology if you are producing phlegm;
- a chest X-ray or CT scan, depending on your circumstances and previous disease;
- an agreed follow-up appointment and clear advice about when to make contact sooner.
Follow-up matters because CPA can change gradually. Monitoring gives your team the chance to spot a concerning pattern early, before symptoms become severe or lung damage progresses.
Symptoms to report after stopping treatment
Many symptoms of CPA overlap with other lung conditions, infections and everyday fluctuations in health. A single bad day does not necessarily mean that CPA has returned. But it is sensible to contact your clinical team if you notice a persistent or unexplained change, particularly if it is getting worse.
Report:
- increasing cough, sputum or chest discomfort;
- worsening breathlessness beyond your usual pattern;
- new or increasing tiredness, fevers, sweats or loss of appetite;
- unexplained weight loss;
- coughing up blood, even in a small amount;
- a new chest infection that is not improving as expected;
- any concern that you are becoming less able to manage normal daily activity.
Seek urgent medical advice for significant coughing up of blood, severe or rapidly worsening breathlessness, severe chest pain, collapse, confusion or feeling acutely unwell.
If CPA returns, what happens next?
A return of symptoms or a worrying test result does not automatically mean you will need to restart exactly the same treatment immediately. Your team will first assess what has changed and whether CPA is the cause. They may compare scans, repeat blood or sputum tests, look for a bacterial infection or another explanation, and review your medicines.
If CPA appears active again, options may include:
- restarting the previous antifungal if it was effective and remains safe for you;
- using a different antifungal medicine or formulation;
- checking antifungal levels, absorption and medicine interactions;
- testing a fungal sample for antifungal resistance where possible;
- treating a co-existing bacterial or other respiratory infection;
- seeking input from a specialist aspergillosis, respiratory or infectious diseases team.
For some people, long-term antifungal treatment is the best way to keep CPA controlled. For others, treatment can be used in periods when the disease is active, with careful observation at other times. The aim is not to keep everyone on treatment forever; it is to find the safest and most effective plan for each person.
Managing the worry of stopping
It can feel unsettling to stop a medicine that has become part of your routine, even when it has caused side effects. You may worry that symptoms will return or that you will not notice a change quickly enough. These feelings are understandable.
It can help to leave an appointment with a clear plan:
- What signs should I look out for?
- Who should I contact if I am worried?
- When will my next blood test, scan or review be?
- What would make us restart treatment?
- Are there practical ways to manage my underlying lung condition and reduce the risk of chest infections?
You do not have to wait until you feel very unwell to raise a concern. Equally, try not to interpret every cough, tired day or chest infection as definite relapse. Your team can help put changes into context.
Questions to ask at your appointment
- What evidence suggests my CPA is stable enough to consider stopping treatment?
- What is the main reason for stopping now: stability, side effects, resistance or another issue?
- What features of my CPA affect my own risk of relapse?
- How will I be monitored after stopping?
- Which symptoms should prompt me to contact the team?
- What options would we consider if my CPA becomes active again?
- Can we review my other medicines, supplements and inhalers for interactions?
The bottom line
Stopping antifungal treatment for CPA is possible for some people, but it needs individual planning and follow-up. A period off treatment can be a positive step when the disease is stable or the burden of treatment is too great. It is not an all-or-nothing decision: if CPA becomes a
Face Masks and Aspergillosis: Dust, Gardening and Respiratory Viruses
Face masks and respirators can reduce the amount of dust, fungal material and respiratory-virus particles that you breathe in. They are most useful for short periods of higher exposure—not as something that people with aspergillosis need to wear whenever they go outside.
This guide explains when a mask may be helpful, how to choose one, and what else matters when dealing with dust, compost, mould or respiratory viruses.
Key points
- For dust, compost, mouldy material and similar tasks, a well-fitting FFP2 or FFP3 respirator offers substantially more protection than a cloth face covering or standard surgical mask.
- A mask is most useful during unusually dusty or mouldy activities. Ordinary outdoor life, such as walking, sitting in a garden or meeting friends, does not usually require one.
- Fit matters as much as filter type. Air leaking around the sides bypasses the filter.
- Masks reduce exposure; they do not make it safe to tackle major mould contamination, demolition work or heavily dusty jobs yourself.
- For respiratory viruses, a well-fitting respirator can be a reasonable extra precaution in crowded, poorly ventilated indoor settings—particularly during a local wave of infection or if you have been advised that you are at higher risk.
Why might someone with aspergillosis use a mask?
Aspergillus and other fungal spores are naturally present in outdoor and indoor air. Completely avoiding them is impossible and, for most people, neither necessary nor helpful.
However, some activities can disturb large amounts of dust, soil, compost, decaying vegetation or mouldy material. This can temporarily increase exposure to fungal spores and other particles that may irritate the airways. People with aspergillosis, severe asthma, bronchiectasis, chronic lung disease or a weakened immune system may prefer to reduce these higher exposures.
A suitable respirator can be one part of that approach. It works best alongside avoiding unnecessary dust, improving ventilation and asking someone else to undertake a task when that is the safer option.
When is a mask most useful?
Consider a well-fitting particulate respirator for short periods of higher exposure, for example:
- opening bags of compost or potting mix;
- turning compost heaps or handling rotting leaves;
- digging dry soil, sweeping sheds, garages or lofts, or working with mulch, bark or wood chippings;
- dusty DIY, sanding, drilling or renovation work;
- entering an area with visible mould or a persistent musty smell while it is being assessed;
- visiting farms, stables, grain stores or other unusually dusty environments;
- periods of wildfire smoke or very poor particulate air quality, where avoiding the exposure completely is not practical.
For some people—particularly those who are severely immunosuppressed or have previously been advised to avoid these exposures—the better option is not to do the task at all. A mask reduces exposure; it does not remove every risk.
Dusty jobs: move them outside where possible
Avoid creating or disturbing dust, compost, mouldy material or debris in enclosed spaces such as sheds, garages, lofts, greenhouses or poorly ventilated rooms. Particles can build up in the air and remain suspended after the work has stopped.
- Move the task outdoors where practical, away from doors and open windows.
- Do not dry-sweep, use compressed air or shake dusty items indoors.
- Open bags of compost and pot plants outside, not in a shed, garage or conservatory.
- For major mould, water damage, demolition or heavily contaminated spaces, ask somebody else or a competent professional to do the work.
A well-fitting FFP2 or FFP3 respirator can reduce exposure, but it does not replace avoiding the task, moving it into fresh air or controlling the source of dust.
Bonfires, fireworks and smoke
Bonfire smoke contains fine particles and gases that can irritate the airways and worsen cough, wheeze or breathlessness. Fireworks can also temporarily increase local particle pollution. This is particularly relevant around Bonfire Night and during local events.
- Avoid standing near bonfires or downwind of smoke where possible.
- Choose a viewing position well away from the smoke, or watch from indoors if your lungs are particularly sensitive.
- Keep windows and external vents closed temporarily if smoke is entering your home, then ventilate again once the air has cleared.
- An FFP2 or FFP3 respirator may reduce inhalation of smoke particles, but it does not filter all gases in smoke and should not be treated as a reason to remain in heavy smoke.
Leave the area and seek medical advice if smoke exposure causes significant or persistent worsening of breathing symptoms.
When is a mask usually not needed?
Most people with aspergillosis do not need to wear a mask for normal time outdoors. That includes sitting in the garden, walking down the street, visiting friends or taking ordinary exercise.
It can be easy to become anxious about fungal spores after a diagnosis, especially when symptoms have been difficult to manage. But treating all outdoor air as dangerous can unnecessarily restrict activity, confidence and social life. A more useful approach is to identify clearly high-exposure situations and take proportionate precautions.
Which type of mask should I choose?
Not all face coverings are designed to protect the wearer from fine airborne particles. For dust, mould and fungal spores, look for a properly certified particulate respirator.
| Type | Protection for dust and fungal spores | When it may be useful |
|---|---|---|
| Cloth face covering | Low and variable | Not suitable for dusty, compost or mould exposure |
| Standard surgical mask | Limited wearer protection | Can reduce spread from someone who is unwell, but is not designed for dusty or mouldy tasks |
| FFP2 respirator | Good, when it fits well | Suitable for many short, higher-exposure tasks |
| FFP3 respirator | Higher protection, when it fits well | Useful for higher-exposure tasks or where additional protection is advised |
| Reusable half-mask respirator with P3 filters | High protection, when correctly selected and fitted | May suit people who frequently undertake dusty work; requires cleaning, storage and filter replacement |
FFP2 and FFP3 are European/UK respirator standards. An FFP2 respirator is designed to filter at least 94% of test particles; an FFP3 respirator at least 99%, when used correctly. The real-world benefit depends heavily on fit and whether the task is suitable to do at all.
Do not rely on products described only as “anti-dust”, “fashion”, “reusable fabric” or “HEPA-style” masks without a recognised respirator standard. A filter only works when air is drawn through it rather than around it.
Getting a good fit
A respirator should cover both your nose and mouth and sit closely against the face. If it feels very loose, slips down, leaves obvious gaps or blows air strongly towards your eyes, it is unlikely to offer its intended protection.
- Choose a size and shape that fits comfortably from the bridge of your nose to beneath your chin.
- Press the nose clip into shape and adjust the straps according to the manufacturer’s instructions.
- Try more than one model if necessary; different designs fit different faces.
- Facial hair where the mask seals against the face can substantially reduce protection.
- Do not modify, cut or puncture a respirator.
- Replace a disposable respirator if it becomes damaged, damp, visibly dirty or difficult to breathe through.
Workplaces that require tight-fitting respiratory protective equipment should have formal selection, training and fit-testing arrangements. For occasional home use, follow the manufacturer’s fitting instructions carefully and choose a mask that genuinely seals comfortably.
Gardening, compost and outdoor dust
Gardening can be enjoyable, active and good for wellbeing. You do not need to give it up simply because you have aspergillosis. The main concern is avoiding activities that create a dense cloud of dust or disturb mouldy, decaying material close to your face.
Useful precautions include asking someone else to open compost bags, dampening very dry soil before working with it, avoiding leaf clearing on windy days and washing hands after gardening. Change clothes and shower if you have been heavily exposed to dust or plant material.
If you regularly garden, an FFP2 respirator may be a practical option for particular jobs. An FFP3 respirator may be preferable for more obviously dusty work, but it can feel more restrictive. Comfort matters: a respirator that you can wear correctly for the whole task is more useful than a higher-rated one that you repeatedly need to remove.
See our Gardening Safely With Aspergillosis guide for broader advice on soil, compost and mould exposure.
Mould in the home: a mask is not the solution
Do not use a mask as a reason to clean extensive mould growth yourself. Brushing, dry-scraping or disturbing mouldy materials can release dust and spores. Significant mould, recurring damp, a musty smell, water damage or a structural leak should be investigated and dealt with at its source.
For a small, isolated patch, the best approach depends on your health, the location and the cause of the mould. If you have a serious lung condition, ask somebody else to undertake straightforward cleaning where possible. Visible mould, widespread contamination or repeated growth usually needs a landlord, housing provider, competent contractor or ventilation specialist—not just surface treatment.
Read our Housing, Damp and Mould hub for advice on damp homes and obtaining repairs.
Masks and respiratory viruses, including COVID-19
Respiratory viruses can trigger a flare-up of asthma, bronchiectasis and other lung conditions. COVID-19 continues to circulate alongside influenza, RSV and other viruses. A well-fitting FFP2 or FFP3 respirator can be a personal layer of protection in crowded or poorly ventilated indoor settings, particularly during a period of high local illness, when travelling, or when you need to be around someone who is unwell.
It is a personal, risk-based choice—not a requirement to withdraw from ordinary life. Other useful measures include vaccination when offered or recommended, good ventilation, avoiding close contact when you are unwell, and asking visitors with respiratory symptoms to postpone where practical.
If you develop symptoms of COVID-19 and are eligible for COVID-19 treatments, follow the NHS advice on testing and contact your GP, NHS 111 or specialist team promptly if you test positive.
What if I find masks difficult to wear?
Many people find respirators uncomfortable, hot, claustrophobic or tiring, particularly if they already experience breathlessness or anxiety. You are not failing if you struggle with them.
- Try different shapes and sizes while sitting somewhere calm before using one for a task.
- Start with short periods and remove the mask in cleaner air if you become distressed or uncomfortable.
- Choose the least demanding option that gives appropriate protection for the task.
- Plan rest breaks, especially in hot weather or during physical work.
- If wearing a respirator causes dizziness, marked breathlessness or chest discomfort, leave the exposure, remove the respirator and seek medical advice if symptoms do not settle.
If you have significant heart or lung disease, ask your healthcare professional for individual advice before using a tight-fitting respirator for strenuous work.
Further information
- Air Quality hub
- Gardening Safely With Aspergillosis
- Housing, Damp and Mould hub
- Seasonal Changes and Aspergillosis
This information is for general education. The precautions appropriate for you depend on the type of aspergillosis you have, your other lung conditions, your immune system and your clinical team’s advice.
A rapid blood test that can support earlier diagnosis of CPA
Chronic pulmonary aspergillosis (CPA) can be difficult to diagnose. Its symptoms — including cough, tiredness, weight loss, breathlessness and coughing up blood — can overlap with other lung conditions such as tuberculosis (TB), bronchiectasis, COPD and lung cancer.
Diagnosis usually brings together several pieces of information: symptoms, lung scans, microbiology results and blood tests for antibodies to Aspergillus. No single test can diagnose CPA on its own.
A simple test with an important role
In 2019, researchers at the University of Manchester and the National Aspergillosis Centre evaluated a rapid blood test called the LD Bio Aspergillus ICT. The test looks for antibodies made by the immune system in response to Aspergillus.
It uses a small blood sample and does not need complex laboratory equipment. This means it can potentially provide a result more quickly and may be particularly valuable in places where specialist laboratory testing is difficult to access.
What did the study find?
The Manchester study compared blood samples from 154 people with CPA and 150 healthy volunteers. In that group, the test correctly identified many people with CPA and correctly gave a negative result for most people without the condition.
This was encouraging because a rapid, affordable blood test could help clinicians investigate possible CPA sooner — especially in countries where TB is common and access to specialist fungal diagnostics is limited.
Why earlier diagnosis matters
CPA can gradually damage the lungs if it is not recognised and treated. It often develops in lungs already affected by a previous condition, including TB, COPD, bronchiectasis, sarcoidosis or previous lung surgery.
Earlier recognition gives clinicians the opportunity to arrange the right scans and laboratory tests, consider treatment where appropriate, and monitor lung health before further damage occurs.
A blood test is only one part of the picture
A positive antibody test does not automatically mean someone has CPA. Some people may have antibodies because they have encountered Aspergillus before, while others with CPA may not produce a clearly positive result. Results must therefore be interpreted alongside symptoms, CT or X-ray findings, sputum or other microbiology tests, and the person’s medical history.
Different tests are used in different hospitals and countries. Your clinical team will choose the investigations that are appropriate for you.
What this means for patients
The development and evaluation of practical diagnostic tests is important progress, particularly for people who may otherwise face long delays before CPA is considered. If you have ongoing respiratory symptoms, lung damage from a previous illness, or are worried about CPA, speak to your respiratory team or GP. They can decide whether further investigation or specialist advice is needed.
Read more: Chronic pulmonary aspergillosis (CPA) and IgG and IgE blood tests explained.
Further reading
Stucky Hunter E, Richardson MD, Denning DW. Evaluation of LD Bio Aspergillus ICT lateral flow assay for IgG and IgM antibody detection in chronic pulmonary aspergillosis. Journal of Clinical Microbiology. 2019.
Reviewed: September 2026
Understanding sputum results: bacteria, fungi and Aspergillus
If you have aspergillosis, bronchiectasis, cystic fibrosis or another long-term lung condition, your clinical team may ask you to provide a sputum sample. The laboratory can look for bacteria, fungi and other organisms that may be present in the mucus from your lungs.
Results can be useful, but they are only one part of the picture. A laboratory result does not automatically mean you have an infection that needs treatment.
Why do I need sputum tests?
Damaged or widened airways can make it easier for mucus to collect and for microorganisms to remain in the lungs. Sputum testing can help your team understand whether a particular bacterium or fungus might be contributing to new symptoms, repeated flare-ups or a change in your lung health.
Samples may be requested when you are more unwell than usual, before starting treatment, during treatment, or as part of regular monitoring.
What can a sputum result show?
A sputum culture may identify bacteria, fungi or both. Common examples include:
- Aspergillus – a fungus that can be linked to several different lung conditions, including allergic bronchopulmonary aspergillosis (ABPA), Aspergillus bronchitis and chronic pulmonary aspergillosis (CPA).
- Pseudomonas aeruginosa – a bacterium that is more common in people with bronchiectasis or cystic fibrosis.
- Other bacteria – such as Haemophilus influenzae, Staphylococcus aureus or Moraxella catarrhalis.
Sometimes no significant organism is grown, even when a person has symptoms. This can happen for several reasons, including the quality of the sample, recent antibiotics or antifungal treatment, and the limits of laboratory testing.
Does a positive result always mean infection?
No. An organism can sometimes be present without causing an active infection or being the main reason for symptoms. This is often described as colonisation. It does not mean that the result should be ignored, but it does mean that it needs interpreting carefully.
Your team will consider the result alongside your symptoms, sputum changes, chest imaging, lung function, blood tests and previous cultures. Repeated findings can be more informative than a single sample.
When bacteria and fungi are both found
It is possible for more than one organism to be present in the same person. For example, Aspergillus and Pseudomonas may both be found in people with bronchiectasis or cystic fibrosis.
This matters because worsening symptoms may not have one simple cause. Research suggests that bacteria, fungi, the immune system and damaged airways can all influence one another. However, finding both organisms does not automatically mean that both need treatment, or that one is causing the other.
The practical point is that your clinical team should look at the whole respiratory picture rather than treating a laboratory result in isolation.
How are results used?
Depending on the situation, a result may lead to further tests, closer monitoring, changes to airway-clearance support, or discussion of antibiotic or antifungal treatment. Sometimes the safest plan is to monitor rather than treat immediately.
Do not start, stop or change antibiotics or antifungal medicines based on a sputum result without advice from your prescribing team. These medicines can have important side effects and interactions, and treatment should be tailored to you.
How can I give the best sample?
- Use the sterile container supplied by your clinic or GP.
- Try to cough up mucus from your chest rather than saliva from your mouth.
- Follow any instructions about timing, particularly if you are taking antibiotics or antifungal medicines.
- Return the sample promptly, as advised by the service collecting it.
If you cannot produce sputum but your team needs a sample, tell them; they may be able to suggest other options.
Key message
Sputum testing helps build a picture of what may be happening in your lungs. A positive result can be important, but it does not make a treatment decision on its own. Your symptoms, repeated results and overall lung health all matter.
This page provides general information and does not replace advice from your own clinical team.
Airway clearance techniques: managing mucus with aspergillosis
Common airway-clearance techniques
Most airway-clearance routines use a combination of breathing, positioning and controlled coughing. Your physiotherapist will help you find the combination that clears mucus effectively without leaving you breathless or exhausted.
Breathing control
Breathing control means relaxed, gentle breathing—usually in through the nose and out through the mouth—at a pace that feels comfortable. It is used between more active parts of a routine to settle the airways, reduce breathlessness and avoid a cycle of hard coughing.
Active cycle of breathing techniques
The active cycle of breathing techniques (ACBT) is widely used and does not need any equipment. It usually combines:
- breathing control to keep the chest relaxed;
- deep breaths to help air move behind mucus in smaller airways; and
- huffing to move mucus upwards, followed by a cough only when mucus is ready to come out.
A huff is a firm, controlled breath out through an open mouth, as if you were steaming up a mirror. A longer, gentler huff can help move mucus from smaller airways; a shorter, sharper huff may help bring mucus from the larger airways into the mouth. Your physiotherapist can show you how much effort to use. Repeated hard coughing is often less effective and can make the airways more irritated.
Postural drainage and positioning
Postural drainage uses gravity to help mucus move from a particular part of the lung towards the larger airways. This may involve sitting upright, lying on one side, lying on your front, or using pillows to support a particular position. You may stay in each position for a few minutes while using breathing control, deeper breaths and huffs.
Many people still find postural drainage very helpful, especially where mucus regularly seems to sit in one area of the chest. Your scan results can help a physiotherapist decide which positions are likely to be most useful.
Traditional head-down positions are not right for everyone. They may worsen reflux, make some people dizzy or uncomfortable, and can be unsuitable with certain heart, spine or breathing problems. There are often modified, non-head-down positions that can still be effective. Ask your physiotherapist to check your technique rather than trying positions from the internet.
PEP and OPEP devices
Positive expiratory pressure (PEP) devices are small handheld devices that you breathe out through. The gentle resistance helps keep smaller airways open during breathing out, which may allow air to get behind mucus. Oscillating PEP (OPEP) devices also create vibrations that can help loosen secretions.
Examples include Aerobika, Acapella and Pari O-PEP devices. A typical routine may involve several breaths through the device, followed by breathing control and a huff or cough. The resistance setting, number of breaths and timing should be chosen with a respiratory physiotherapist, not copied from someone else.
Manual techniques
Some people benefit from hands-on techniques such as percussion, vibrations or chest-wall support. These are usually carried out by a physiotherapist or a carer who has been taught the method. They are not required by everyone, but may be useful when someone is very tired, weak or unable to clear mucus independently.
Exercise and movement
Walking, gentle exercise and changes of position can sometimes help loosen mucus and support general lung health. Exercise does not replace an individual airway-clearance plan, but it can be a useful part of it. Pulmonary rehabilitation can provide supported exercise and education for eligible patients.
Hair loss and aspergillosis treatment: support and advice
Hair loss or thinning can be upsetting. It can affect confidence, identity, relationships and day-to-day life—especially when you are already managing aspergillosis. If this is happening to you, you are not being vain, and you do not have to deal with it alone.
Hair loss can sometimes occur during treatment with medicines used for aspergillosis, including some antifungal medicines. However, it can also have other causes, such as a recent illness, stress on the body, weight loss, low iron, thyroid problems, other medicines or a separate scalp condition. It is important not to assume the cause.
Tell your clinical team
Let the doctor, nurse or pharmacist who prescribes your treatment know if you notice new or worsening hair loss. They can review the timing, your medicines and other possible causes. They may arrange blood tests or suggest that your GP or a dermatology specialist becomes involved.
Do not stop, reduce or miss doses of an antifungal medicine because of hair loss without discussing it with your prescribing team. Aspergillosis can become more difficult to control if treatment is changed suddenly. There may be options to consider, but this needs specialist advice.
It can help to make a note of when the hair loss began, whether it is thinning or patchy, any scalp symptoms, recent illnesses and changes to medicines. Photographs taken in similar light over time may also help show whether it is changing.
When should I seek medical advice?
Arrange a GP or clinical-team review if hair loss is new, rapid, patchy, persistent or causing you distress. Seek advice sooner if you also have a painful, inflamed, scaly or infected-looking scalp, or other new symptoms such as marked tiredness, weight change or changes in your skin or nails.
Be careful with online treatments and supplements
Hair-loss products, vitamins and herbal supplements are widely advertised, but they may not be appropriate for everyone. Some can interact with prescribed medicines or affect blood tests. Check with your pharmacist or specialist team before starting a hair supplement, minoxidil or any other treatment.
Practical ways to cope
There is no right way to respond to hair loss. Some people prefer not to cover it; others find that changing their hairstyle, wearing a hat, scarf or wig, or using cosmetic options helps them feel more like themselves. These are personal choices, not something you have to do.
- Talk to someone you trust. Explaining what has changed and how it makes you feel can make it easier for family or friends to offer the support you want.
- Consider a hairdresser consultation. An experienced hairdresser may suggest a cut or style that works well with thinning or patchy hair.
- Explore head coverings or wigs. Some people prefer scarves, hats, hairpieces or wigs; others do not. It can be useful to try options without pressure to choose one.
- Ask about NHS wig support. Wigs may be available on the NHS in some circumstances, although charges and eligibility vary.
Looking after your wellbeing
Hair loss can bring sadness, anger, anxiety or a feeling of lost control. If it is affecting your mood, self-esteem or willingness to leave the house, tell your GP or clinical team. Emotional support is part of good healthcare.
You may also find it helpful to speak with others who understand hair loss, alongside the aspergillosis community. Alopecia UK offers information and support for people affected by different types of hair loss.
Further information
Key message
Hair loss may be related to treatment, but it needs proper review because there can be several causes. Raise it early with your clinical team, do not alter antifungal treatment alone, and ask for support with both the practical and emotional impact.
This page provides general information and does not replace advice from your own clinical team.